Skip to main content
Erschienen in:

30.10.2024 | original report

Implantable catheter chambers: a 14-year descriptive study

verfasst von: Anas Erragh, Salma Bellaftouh, Safia Chaabi, Yassine Hafiani, Afak Nsiri, Rachid Alharrar

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2025

Einloggen, um Zugang zu erhalten

Summary

Introduction

Implantable catheter chambers are widely used devices during the treatment of cancer whether for taking blood samples or for chemotherapy infusion. The placement of this type of chamber has significantly improved the care of cancer patients. However, it can expose the patients to numerous complications which may be related to the device itself or the implantation technique.

Aim

The aim of this single-center study was to determine the epidemiological profile of patients who had undergone this procedure, identify the main indications for implantation, and most importantly to compare the techniques used for implantation.

Methods

We conducted a retrospective descriptive study at the surgical intensive care unit of Ibn Rochd University Hospital in Casablanca from January 2009 to December 31, 2022, including 3197 patients who had an implantable catheter chamber placed. Data were collected prospectively.

Results

The average age of the 3197 patients was 51 years; 63.60% of them had breast cancer. The most dominant age group was patients between 40 and 60 years. The main indication for the implantable chamber was chemotherapy for breast cancer at a rate of 63.60%, followed by gastrointestinal cancer at 15.09%. It is noted that 81.26% of the patients had a right-side approach and the most punctured vein was the right internal jugular vein (IJV) with a rate of 70.49%, followed by the left IJV at 28.37%. The percutaneous approach was the only method used. Percutaneous puncture of the right IJV was the preferred technique due to anatomical landmarks and accessibility of the vein. Ultrasound guidance during the puncture of the vein in question was used in 87% of patients. The average duration of the procedure was between 10 and 15 min. No per operative complications (arterial puncture, hematoma, pneumothorax) were observed. Prophylactic antibiotic therapy was administered to all patients.

Conclusion

The placement of the chamber by ultrasound-guided percutaneous access to the IJV is a minimally invasive and safe technique that complies with the specifications of the 2008 Standards, Options and Recommendations (SOR) recommendations. Less invasive than surgical access and safer than “blind” puncture, it constitutes a reliable, simple procedure that minimizes subsequent risks to the greatest extent possible.
Literatur
1.
Zurück zum Zitat Barbut F, Soukouna S, Lalande V, Garcia M‑L, Neyme D, de Gramont A, et al. Cathéters à chambre implantable : épidémiologie des complications et étude microbiologique des dispositifs après ablation. Pathol Biol. 2004;52(10):566–74.CrossRefPubMed Barbut F, Soukouna S, Lalande V, Garcia M‑L, Neyme D, de Gramont A, et al. Cathéters à chambre implantable : épidémiologie des complications et étude microbiologique des dispositifs après ablation. Pathol Biol. 2004;52(10):566–74.CrossRefPubMed
2.
Zurück zum Zitat Thevenet T, Girard R, Caillot J. Etude rétrospective des c omplications précoces des cathéters à chambre implantable. Hygiène. 2009;17(6):443–52. Thevenet T, Girard R, Caillot J. Etude rétrospective des c omplications précoces des cathéters à chambre implantable. Hygiène. 2009;17(6):443–52.
3.
Zurück zum Zitat Sansivero GE. Venous anatomy and physiology. Considerations for vascular access device placement and function. J Intraven Nurs. 1998;21:107–14. Sansivero GE. Venous anatomy and physiology. Considerations for vascular access device placement and function. J Intraven Nurs. 1998;21:107–14.
10.
Zurück zum Zitat Nguyen V, Jarry J, Farthouat P, Bourilhon N, Milou F, Michel P. Pose de chambre implantable par abord percutané échoguidé : à propos d’une série de 102 patients [Ultrasound-guided percutaneous insertion of implantable venous devices: a review of 102 patients]. J Mal Vasc. 2013;38(1):6–12. https://doi.org/10.1016/j.jmv.2012.11.004. French.CrossRefPubMed Nguyen V, Jarry J, Farthouat P, Bourilhon N, Milou F, Michel P. Pose de chambre implantable par abord percutané échoguidé : à propos d’une série de 102 patients [Ultrasound-guided percutaneous insertion of implantable venous devices: a review of 102 patients]. J Mal Vasc. 2013;38(1):6–12. https://​doi.​org/​10.​1016/​j.​jmv.​2012.​11.​004. French.CrossRefPubMed
17.
Zurück zum Zitat Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery. 1982;92(4):706–12.PubMed Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery. 1982;92(4):706–12.PubMed
18.
Zurück zum Zitat el Kabiri H, El Hammoumi M, Traibi A, El Oueriachi F, Arsalane A. Les chambres à cathéters implantables: à propos d’une série de 970 cas [Catheters with implantable chamber: report of a series of 970 cases]. Pan Afr Med J. 2012;12:72.PubMedPubMedCentral el Kabiri H, El Hammoumi M, Traibi A, El Oueriachi F, Arsalane A. Les chambres à cathéters implantables: à propos d’une série de 970 cas [Catheters with implantable chamber: report of a series of 970 cases]. Pan Afr Med J. 2012;12:72.PubMedPubMedCentral
20.
Zurück zum Zitat Champault G. Cathéters totalement implantables pour chimiothérapie anticancéreuse. Expérience française de 325 cas [Completely implantable catheters for anticancer chemotherapy. A French experience of 325 cases. J Chir (paris). 1985;122(4):269–72.PubMed Champault G. Cathéters totalement implantables pour chimiothérapie anticancéreuse. Expérience française de 325 cas [Completely implantable catheters for anticancer chemotherapy. A French experience of 325 cases. J Chir (paris). 1985;122(4):269–72.PubMed
Metadaten
Titel
Implantable catheter chambers: a 14-year descriptive study
verfasst von
Anas Erragh
Salma Bellaftouh
Safia Chaabi
Yassine Hafiani
Afak Nsiri
Rachid Alharrar
Publikationsdatum
30.10.2024
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 1/2025
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-024-01000-9